Search hospitals > Minnesota > Saint Paul
Minnesota Oncology Hematology PA-Woodbury
Claim this profileSaint Paul, Minnesota 55125
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
417 reported clinical trials
12 medical researchers
Summary
Minnesota Oncology Hematology PA-Woodbury is a medical facility located in Saint Paul, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Minnesota Oncology Hematology PA-Woodbury is involved with conducting 417 clinical trials across 509 conditions. There are 12 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
97 reported clinical trials
159 drugs studied
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Minnesota Oncology Hematology PA-Woodbury
Breast Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Multiple Myeloma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Minnesota Oncology Hematology PA-Woodbury?
Minnesota Oncology Hematology PA-Woodbury is a medical facility located in Saint Paul, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Minnesota Oncology Hematology PA-Woodbury is involved with conducting 417 clinical trials across 509 conditions. There are 12 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Minnesota Oncology Hematology PA-Woodbury located?
**Minnesota Oncology Hematology PA-Woodbury**
- **Location:** 310 Smith Ave N, Suite 100, Saint Paul, MN
- **Phone:** (651) 251-5500
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance queries at Minnesota Oncology Hematology PA-Woodbury, patients can call (844) 317-4673 to connect with a social worker for support with financial assistance, transportation, and more. The Patient Benefit Representative can assist with understanding treatment costs, setting up financial plans, and navigating drug costs. Additionally, the Angel Foundation offers cash grants for qualified patients to help with non-medical financial needs during treatment.
What insurance does Minnesota Oncology Hematology PA-Woodbury accept?
Minnesota Oncology Hematology PA accepts various insurance plans, including Blue Cross and Blue Shield of Minnesota. They have been recognized by Blue Cross Blue Shield Minnesota for quality in value-based cancer care. For detailed information on accepted insurance plans, contact the healthcare provider directly or visit their website.
What awards or recognition has Minnesota Oncology Hematology PA-Woodbury received?
Minnesota Oncology Hematology PA-Woodbury, located in Saint Paul, Minnesota, is recognized by Blue Cross Blue Shield Minnesota as a Blue Distinction® Center for Cancer Care, highlighting its high-quality and cost-effective cancer treatment. It is also a member of the Metro Minnesota Community Oncology Research Consortium, offering patients access to clinical trials and cancer care research.